New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2013
05:46 EDTVNDAVanda Pharmaceuticals upgraded to Buy from Hold at Jefferies
Jefferies upgraded Vanda Pharmaceuticals citing positive sleep efficacy data for the company's tasimelteon drug. The firm raised its price target for shares to $6.00 from $3.50.
News For VNDA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2015
13:21 EDTVNDAVanda Pharmaceuticals volatility increases
Vanda Pharmaceuticals February call option implied volatility is at 87, March is at 91; compered to its 26-week average of 79 according to Track Data, suggesting large price movement.
January 16, 2015
09:31 EDTVNDAVanda announces listing of new Fanapt patent in FDA Orange Book
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use